Zobrazeno 1 - 10
of 237
pro vyhledávání: '"R Epelbaum"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The American Journal of Dermatopathology. 28:434-437
Pleomorphic small/medium-sized cutaneous T-cell lymphoma is a recently recognized rare type of cutaneous T-cell lymphoma which is clinicopathologically different from mycosis fungoides and Sezary syndrome. By definition the phenotype of the neoplasti
Publikováno v:
Gastrointestinal Oncology. 4:127-131
Autor:
Steven J. O’Day, Emilia Crisanti, Massimo Di Maio, Peter K. Vogt, Manuela Pacyna-Gengelbach, Marija Gamulin, Giulio C. Spagnoli, Simona Messinese, S. Pyrhönen, Kurt Kletter, D.M. Katschinski, Tomotaka Kawayama, K.E. Rosenblatt, Tetsuya Yamamoto, Takashi Sugimura, R. Bendardaf, Chang Ok Suh, Keisuke Matsusaki, Takuji Okusaka, Y. Kishimoto, Daniele Turci, N. Malamos, Faraj Terro, Regina Deck, J. Laine, E. Karyda, Bert Hildebrandt, Takashi Fujishita, Genichi Nishimura, Cesare Gridelli, J. Tímár, Yuichi Oshita, K. Drumea, Ross E. Turner, W. Longo, Tsuyoshi Kimura, Rafael M. Nagler, Wataru Yasui, Tatsuhiko Kashii, Ofer Ben-Itzhak, Martha Hoffmann, Shuichi Okada, Hitoshi Tsuda, N. Haim, H. Lamlum, Monika Jermann, Koichi Shimizu, Hirofumi Nakayama, H. Kujari, Markus Raderer, Giuseppe D'Aiuto, Z. Orosz, H. Bailey, Sachio Fushida, Hejing Wang, M. Ben-Shachar, Anna Cappellini, Takashi Fukutomi, Ira Minkov, Jacques Hugon, Sandrine Robert, Frank Trimoreau, Johanna Skoglund, Yasuhiko Kitadai, Francesco Salvestrini, Maria Grazia Cantù, Shoko Oishi, Lars Meyer, Francesco Perrone, A. Kuten, Emanuela Rossi, Z. Voulgaris, Gunnar Arbman, Anna Emterling, Francesco Nuzzo, Peter D. Boasberg, Bernhard C. Pestalozzi, J. Hasegawa, R. Epelbaum, G. Shiota, Catherine Yardin, Michiya Matunami, Kazuaki Miyamoto, Kuniko Wakazono, John Carstensen, Tomislav Oresic, A. Ardavanis, Shoshana Ben-Eliezer, Hiroshi Funaki, Gerardo Amabile, Hedviga Kerner, Robert Šeparović, Luigi Terracciano, Alexander Becherer, Eleni Petridou, Y. Maeda, J. Finet, Hong Zhang, N. Miura, Takashi Tani, Massimo Loda, Toshimitsu Saisho, Antonio Juretić, W. Gillis, R. Ristamäki, K. Kalbakis, J.D.P. van Dijk, Hee Chul Park, M.E. Stein, Pierpaolo Correale, M Sabatino, Agnieszka Pietas, Roberto Petrioli, A.M. Westermann, S. Agelaki, Delia Marina Alexe, Michael Heberer, Daniele Pozzessere, Chigusa Morizane, Hisamichi Aizawa, A. Marumoto, Toshikazu Ushijima, Maurizio Marangolo, K. Malas, Oscar S. Breathnach, C.L. Tiggelaar, Antonio Rossi, Rumi Gohara, Takashi Fujimura, Naohide Oue, Itsuro Terada, Koichi Miwa, Gerardo Rosati, A. Bakhshandeh, Hiroshi Fukui, Yukiko Yagi, M. Gergye, Kiyoshi Asada, E. Jager, Kiyomi Taniyama, Masao Ichiki, Elke Schultz-Thater, Ulrich Jäger, Shunji Matsumura, Beth Tamar, Evagelos Spanos, Kyoo Ho Shin, Masato Kayahara, V. Georgoulias, Luigi Manzione, N. Udvarhelyi, Marinshine Gentler, P.Z. Vörde sive Vörding, Andreas Chott, Zbigniew Petrovich, Hideki Ueno, T. Bánfalvi, Diodoro Colarusso, Eric P. Winer, A. Knuth, Sofia Evertsson, J. Zidan, G. Landi, Yukihiro Tatemoto, Takeharu Koga, Ch. Kouroussis, Bozena Sarcevic, Eisaku Ueta, Iver Petersen, Zdenko Krajina, Y. Collan, Andrea de Matteis, Hong Ryull Pyo, V. Labonia, Y. Murawaki, François Labrousse, Hanno Riess, E. Gez, Panagiotis Koukoulomatis, S.O. Peters, Dimitrios Trichopoulos, Virginie Bellet, Teresa Di Palma, Tokio Osaki, Barbara Petit, A. Alexopoulos, T. Nakagawa, Ugo De Giorgi, Tomoko Kamimura, Jose Schneider, K. Gilde, Tim S. Kristedja, Isabelle Pommepuy, A. Neumann, Pat Ames, Tetsuo Ohta, Itasu Ninomiya, Susana M. Campos, G.J. Wiedemann, Guido Francini, Stefania Marsili, E. Tselepatiotis, Antonio Manganelli, Yuan Chen, Toru Rikimaru, Maureen Martin, D. Jager, Kelly Shinn, A. Sano, Bruce E. Johnson, Simone Petersen, H.I. Robins, Xiao-Feng Sun, Shin-ichi Harada
Publikováno v:
Oncology. 64:487-489
Publikováno v:
International journal of oncology. 1(1)
A novel 21 kDa protein (p21) was detected in sera of patients with urogenital tumors by ELISA, using rabbit polyclonal antibodies generated against the p21 polypeptide. Eight out of 11 patients (72%) exhibited a 2-5 fold increase in pre-treatment p21
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 7(3)
The treatment and outcome of primary parotid gland non-Hodgkin's lymphoma (PGL) has rarely been described. This retrospective study documents the clinicopathologic features and treatment results in this relatively rare entity.This study was conducted
Autor:
M E, Stein, M, Ben-Schacher, A, Kuton, N, Haim, A, Kuten, E, Gez, J, Zidan, N, Siegelmann-Danieli, R, Epelbaum
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 10(4)
Primary liver lymphoma (PLL) is a rare lymphoproliferative disorder of unknown etiology. The prognosis in affected patients is poor, consisting of brief remissions, rapidly developing resistance to chemotherapy, early recurrence, and short survival.
Autor:
M E, Stein, A, Kuten, E, Gez, K E, Rosenblatt, K, Drumea, M, Ben-Shachar, J, Zidan, N, Haim, R, Epelbaum
Publikováno v:
Oncology. 64(4)
This retrospective study describes our experience with the diagnosis, treatment, results and long-term follow-up of primary bone lymphoma (PBL).Nineteen patients diagnosed with PBL were reviewed. Seven patients presented with stage I(E) disease, four
Autor:
Alan Hilary Calvert, P. Fargeot, Teresa Gamucci, R. Epelbaum, Peter F. Bruning, Laura Biganzoli, Caroline Lohrisch, Luc Duchateau, Robert E. Coleman, Tanja Cufer, Martine Piccart, Chris Twelves
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(14)
PURPOSE: To compare the efficacy and tolerability of the combination of doxorubicin and paclitaxel (AT) with a standard doxorubicin and cyclophosphamide (AC) regimen as first-line chemotherapy for metastatic breast cancer. PATIENTS AND METHODS: Eligi
Autor:
R, Epelbaum, N, Haim, M, Ben-Shahar, I, Valtuch, D, Faraggi, A, Sharabi-Nov, Y, Ben-Arie, Y, Cohen
Publikováno v:
Harefuah. 140(4)
Between 1972 and 1994, 121 adult patients with advanced Hodgkin's disease received MOPP (M) combination chemotherapy, MOPP alternating with ABVD (M-A) or MOPP and ABV hybrid (M/A). Radiation therapy was given to 1/3 of them. The median age was 35 yea